- AbbVie press release (NYSE:ABBV): Q1 Non-GAAP EPS of $2.46 beats by $0.06.
- Revenue of $13.34B (+8.4% Y/Y) beats by $420M.
- First-Quarter Global Net Revenues from the Neuroscience Portfolio Were $2.282 Billion, an Increase of 16.1 Percent on a Reported Basis, or 17.0 Percent
AbbVie Non-GAAP EPS of $2.46 beats by $0.06, revenue of $13.34B beats by $420M
